Open Access Case Report DOI: 10.7759/cureus.45514 Takotsubo Cardiomyopathy in a Post-COVID Case Amanpreet S. Wasir 1 , Ravi Kalra 1 , Puneet Verma 2 1. Cardiology, Bharati Vidyapeeth University and Medical College, Pune, IND 2. Cardiology, ACE Heart and Vascular Institute, Mohali, IND Review began 09/09/2023 Review ended 09/12/2023 Published 09/18/2023 Corresponding author: Amanpreet S. Wasir, amanpreet.wasir@gmail.com © Copyright 2023 Wasir et al. This is an open access article distributed under the terms of the Creative Commons Attribution License CC-BY 4.0., which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Abstract Takotsubo cardiomyopathy (TTC) is a unique heart disease that mimics the clinical presentation of acute coronary syndrome and is seen more commonly in post-menopausal females. Here, we report a case that presents an ideal documentation of TTC depicting its characteristic clinical features and possible outcomes. TTC usually culminates in a complete reversal of both systolic and diastolic dysfunctions, however in our case of a post-COVID scenario, the persisting, rather worsening diastolic dysfunction might be a residual manifestation of COVID-19 myocarditis. Recent reports have found an increasing prevalence of TTC amidst the COVID-19 pandemic possibly as a result of the emotional and physical stress, and subsequent catecholamine surge caused by the virus in such patients. There might exist an independent association between TTC and the COVID-19 virus. Increased clinical evidence is required to establish the strength of this relationship, if any. Categories: Cardiac/Thoracic/Vascular Surgery, Internal Medicine, Infectious Disease Keywords: left ventricle, takotsubo cardiomyopathy, regional wall motion abnormality, diastolic dysfunction, covid19 Introduction Takotsubo cardiomyopathy (TTC) is best described clinically as transient left ventricular apical ballooning and dysfunction without the presence of obstructive coronary artery disease [1,2]. TTC has a multi-factorial pathophysiology with the majority of the patients classically presenting with some kind of 'stress' [2,3,4]. Amidst the recent outbreak of the SARS-CoV-2 virus, it is now well-known that the virus affects the cardiovascular system in various ways [2,5]. The cardiovascular manifestations of the COVID-19 virus include myocarditis, microvascular damage, endothelial dysfunction, and structural and functional abnormalities of worsening cardiac dysfunction, among others [2,5]. Recent studies have found an increasing prevalence of TTC as an 'acute coronary syndrome mimicker' in patients affected by the COVID19 virus [2,6,7]. The occurrence of TTC in patients with COVID-19 is attributed largely to the emotional and physical stressors that are incubated during the COVID-19 outbreak which in turn trigger a cytokine storm and subsequent catecholamine surge in the body responsible for pre-disposing such patients to TTC [2,3,6,7]. However, the etiopathogenesis and clinical spectrum of the relationship between TTC and the COVID-19 virus remains ill-defined and requires more clinical evidence to establish its strength as a potential independent association. Case Presentation A 68-year-old female presented to the emergency ward of a tertiary care hospital with complaints of sudden onset chest pain, dyspnea, and palpitations. She had a history of hypothyroidism, hypertension, and diabetes, but no significant family history or past history of any cardiovascular disease. She gave a history of mild COVID-19 infection a month ago which was managed symptomatically at home. She recovered over the next two weeks but began to complain of breathlessness on exertion with subsequent relief on taking rest, and bearable exertional chest pain for four to five days prior to admission. Her vitals were: pulse- 69 bpm, blood pressure- 112/56 mmHg, respiratory rate- 20/min, O2 saturation- 95%, afebrile. Electrocardiogram revealed bi-phasic T wave in lead I and symmetrical T wave inversion in leads V1 to V3 and aVL (Figure 1). How to cite this article Wasir A S, Kalra R, Verma P (September 18, 2023) Takotsubo Cardiomyopathy in a Post-COVID Case. Cureus 15(9): e45514. DOI 10.7759/cureus.45514 FIGURE 1: Electrocardiogram showing bi-phasic T wave in lead I and symmetrical T wave inversion in leads V1 to V3 and aVL. Biochemical tests revealed troponin T level to be 137 ng/L (n= <50 ng/L). Coronary angiography revealed normal epicardial coronary arteries (Figure 2), thereby ruling out coronary artery disease. FIGURE 2: (A) Coronary angiogram showing normal left coronary artery. (B) Coronary angiogram showing normal right coronary artery. An echocardiogram revealed an abnormal appearance of the left ventricle (LV) (Figure 3) and regional wall motion abnormalities at rest with left ventricular ejection fraction= 40%. Clinical diagnosis of TTC was thus made, using the reference of the diagnostic criteria proposed by the Mayo Clinic [3]. 2023 Wasir et al. Cureus 15(9): e45514. DOI 10.7759/cureus.45514 2 of 6 FIGURE 3: (A) Echocardiogram: apical four-chamber view showing left ventricular apical ballooning. (B) Echocardiogram: apical-two chamber view showing normal left atrium and abnormal expansion of left ventricle. Also noted, left ventricular regional wall motion abnormalityhypokinesia of mid anterior, all apical & mid segments interventricular septum. The patient was managed with beta-blockers, angiotensin-converting enzyme (ACE) inhibitors, statins, antiplatelets, and diuretics. The patient improved symptomatically and was kept under observation. After three days, a repeat echocardiogram pre-discharge showed no regional wall motion abnormalities with improved left ventricular ejection fraction= 57% following which the patient was discharged on regular follow-up advice. The mitral valve and tissue Doppler findings suggest worsening of grade I to grade II diastolic dysfunction of the left ventricle with abnormal values of mitral valve diastolic blood flow which have not reversed back to normal values even after a significant time lapse post-admission (Figure 4). At the onemonth follow-up, the patient was asymptomatic, involved in regular home activities of daily living, and walking normally with normal effort tolerance. 2023 Wasir et al. Cureus 15(9): e45514. DOI 10.7759/cureus.45514 3 of 6 FIGURE 4: (A and B) - differences in mitral valve and tissue Doppler findings obtained on a subsequent time lapse of four days. On admission, depicting indices; MV E Velocity= 0.84 m/s, MV A Velocity= 1.07 m/s, MV E/A Ratio= 0.78, E/E’ Ratio= 10.28 suggestive of grade I diastolic dysfunction. (C and D) - Pre-Discharge, depicting indices; MV E Velocity= 0.99 m/s, MV A Velocity= 0.87 m/s, MV E/A Ratio= 1.13, E/E’ Ratio= 11.84 suggestive of grade II diastolic dysfunction. Discussion The overall prevalence of TTC is studied to be 1-2% in cases of suspected acute myocardial infarction [3,8]. It has been found that the majority of patients diagnosed with TTC are above the age of 50 years, [9] with a female-to-male ratio of 9:1, [10] indicating that elderly age and female sex are strong independent risk factors of TTC. COVID-19 infection is known to cause a 'cytokine storm' with an associated catecholamine surge in those moderately to severely affected by the virus, which in turn results in predisposing the occurrence of TTC in such patients [2,6,7]. The prevalence of TTC changed from an initial pre-pandemic range of 1.5-1.8% to 7.8% (n=1914 acute coronary syndrome patients studied across four distinct prepandemic timelines) during the pandemic according to a recent retrospective study [7]. Moreover, the impact of the COVID-19 pandemic on physical, psychological, mental, emotional, personal, and social domains has been enormous, which has adversely affected the mental well-being of the community by many-folds, leading to emotional and physical stress, both of which are identified as strong etiological factors for developing TTC [2,11]. In our patient, the left ventricular ejection fraction which had dropped to a low 40% increased to a normal 57% indicating the quick-reversible nature of TTC. Regional wall motion abnormalities of the left ventricle including hypokinesia of mid anterior, apical & mid segments of the interventricular septum also seem to have resolved pre-discharge as were seen previously. The mitral diastolic blood flow has shown a positive trend with a gradually increasing E/A ratio since the episode of TTC from 0.78 to 1.1 pre-discharge. The E/E’ ratio which is indicative of diastolic dysfunction increased from 10.28 initially to 11.84 pre-discharge, suggesting a progressive left ventricular diastolic dysfunction (Figure 4). Importantly even though there is nearly complete reversal of LV systolic dysfunction, grade I diastolic dysfunction has worsened to grade II, suggesting a possible pathological state of the myocardium in TTC, possibly aggravated by the patient's COVID-19 infection, though a baseline derangement of echocardiographic and tissue doppler findings suggesting a persisting diastolic dysfunction in view of age, hypertension and diabetes remains a possibility. In this particular case, there were no other potential triggers found on history and clinical examination that might predispose the development of TTC in our patient. Thus, there exists a possibility of a potential relationship between the previous COVID-19 viral episode and the subsequent development of TTC after approximately a month's duration in our patient. The long-term significance of this still remains unclear, thus the patient needs to be constantly monitored with regular follow-ups. TTC, well-known for its completely reversible nature, may sometimes lead to persistent diastolic dysfunction, which might have fatal complications in the long run [12]. Herein, even though there may be complete recovery on macroscopic grounds, the microscopic recovery is comparatively much slower and 2023 Wasir et al. Cureus 15(9): e45514. DOI 10.7759/cureus.45514 4 of 6 delayed [12]. The systolic and diastolic function may continue to remain abnormal in TTC patients even after the initial ‘recovery phase’ in spite of LV morphology and systolic function being normal [13]. A recent study (n=205; mean age=70±12years; 95% female) showed that the diastolic function improved only in 28% of TTC cases during the recovery phase (mean 38±16 days after admission), whereas, in the remaining 72%, the diastolic function was either unchanged or worsened [14]. Thus, the recovery phase might be delayed or may be incomplete in some TTC cases following its acute onset, and this remains to be studied further. Lastly, there is a paucity of clinical cases which is required to correctly establish the strength of the association between TTC and the COVID-19 virus. An increased prevalence with fuelled research could prove to be the missing link in defining the severity of this association, which will positively reflect in the early identification of cases and better management strategies aimed at improving patient outcomes. Conclusions We present a patient of takotsubo cardiomyopathy (TTC) in a post-COVID-19 scenario wherein the persistent rather worsening left-ventricular diastolic dysfunction might possibly be a result of the catecholamine surge caused by the virus. Clearly, more evidence is needed to strengthen this association. Recent studies have revealed a higher prevalence of TTC associated with viral contagion, possibly due to different physical and emotional stressors caused during the pandemic. Positive efforts in bridging the gaps between the etiopathogenesis of this relationship will reflect in early diagnosis and targeted treatment strategies aimed at the betterment of patient outcomes. Additional Information Author Contributions All authors have reviewed the final version to be published and agreed to be accountable for all aspects of the work. Concept and design: Amanpreet S. Wasir, Ravi Kalra, Puneet Verma Acquisition, analysis, or interpretation of data: Amanpreet S. Wasir, Ravi Kalra, Puneet Verma Drafting of the manuscript: Amanpreet S. Wasir, Ravi Kalra, Puneet Verma Critical review of the manuscript for important intellectual content: Ravi Kalra, Puneet Verma Supervision: Ravi Kalra, Puneet Verma Disclosures Human subjects: Consent was obtained or waived by all participants in this study. Bharati Vidyapeeth University Institutional Ethics Committee issued approval -. Ethical approval: Ethical Committee approval was obtained. Informed consent: Written consent was obtained from the patient. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work. Acknowledgements The authors gratefully acknowledge the contribution of the patient, who consented for their clinical report to be documented and published in the medical literature. References 1. 2. 3. 4. 5. 6. Summers MR, Prasad A: Takotsubo cardiomyopathy: definition and clinical profile. 2013. 10.1016/j.hfc.2012.12.007 Kalra R, Wasir AS, Bhavsar AS, Singh VP, Padwal MK: Takotsubo cardiomyopathy: narrative review with relation to COVID-19. Indian Journal of Clinical Cardiology. 2022, 3:198-206. 10.1177/26324636221109051 Prasad A, Lerman A, Rihal CS: Apical ballooning syndrome (Tako-Tsubo or stress cardiomyopathy): a mimic of acute myocardial infarction. Am Heart J. 2008, 155:408-17. 10.1016/j.ahj.2007.11.008 Sharkey SW, Windenburg DC, Lesser JR, et al.: Natural history and expansive clinical profile of stress (takotsubo) cardiomyopathy. J Am Coll Cardiol. 2010, 55:333-41. 10.1016/j.jacc.2009.08.057 Guo T, Fan Y, Chen M, et al.: Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020, 5:811-8. 10.1001/jamacardio.2020.1017 Sharma K, Desai HD, Patoliya JV, Jadeja DM, Gadhiya D: Takotsubo syndrome a rare entity in covid-19: a systemic review-focus on biomarkers, imaging, treatment, and outcome. SN Compr Clin Med. 2021, 3:62-72. 2023 Wasir et al. Cureus 15(9): e45514. DOI 10.7759/cureus.45514 5 of 6 7. 8. 9. 10. 11. 12. 13. 14. 10.1007/s42399-021-00743-4 Jabri A, Kalra A, Kumar A, et al.: Incidence of stress cardiomyopathy during the coronavirus disease 2019 pandemic. JAMA Netw Open. 2020, 3:e2014780. 10.1001/jamanetworkopen.2020.14780 Kurowski V, Kaiser A, von Hof K, et al.: Apical and midventricular transient left ventricular dysfunction syndrome (tako-tsubo cardiomyopathy): frequency, mechanisms, and prognosis. 2007. 10.1378/chest.070608 Templin C, Ghadri JR, Diekmann J, et al.: Clinical features and outcomes of takotsubo (stress) cardiomyopathy. N Engl J Med. 2015, 373:929-38. 10.1056/NEJMoa1406761 Schneider B, Athanasiadis A, Stöllberger C, et al.: Gender differences in the manifestation of tako-tsubo cardiomyopathy. Int J Cardiol. 2013, 166:584-8. 10.1016/j.ijcard.2011.11.027 Shah RM, Shah M, Shah S, Li A, Jauhar S: Takotsubo syndrome and COVID-19: associations and implications. 2021. 10.1016/j.cpcardiol.2020.100763 Yalta K, Yilmaztepe M, Zorkun C : Left ventricular dysfunction in the setting of takotsubo cardiomyopathy: a review of clinical patterns and practical implications. Cardiac Failure Review. 2018, 4:14-20. 10.15420/cfr.2018:24: 2 Pelliccia F, Kaski JC, Crea F, Camici PG: Pathophysiology of takotsubo syndrome . Circulation. 2017, 135:2426-41. 10.1161/CIRCULATIONAHA.116.027121 Sun T, Ming Z, Liu Z, et al.: Prevalence of diastolic function and clinical impact on long-term outcome in takotsubo cardiomyopathy. Int J Cardiol. 2017, 244:7-12. 10.1016/j.ijcard.2017.06.068 2023 Wasir et al. Cureus 15(9): e45514. DOI 10.7759/cureus.45514 6 of 6